Gentian Diagnostics Grants 485,000 Options to Key Employees

• Gentian Diagnostics granted 485,000 options to key employees under its existing option program on November 6, 2026.
• CEO Matti Heinonen received 100,000 options at a NOK 60 strike price; another 100,000 carry a NOK 44 strike price.
• CFO Njaal Kind received 50,000 options at a NOK 60 strike price; another 50,000 carry a NOK 44 strike price.
• Aleksandra Havelka received 20,000 options at NOK 44; Hanne Kristiansen received 20,000 each at strike prices of NOK 60 and NOK 44.
• Options become exercisable in equal 50% tranches three and four years from allocation, with expiry at five years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gentian Diagnostics ASA published the original content used to generate this news brief via NewsWeb, the disclosure sustem operated by Euronext Oslo (Ref. ID: 202611060427OSLOBORSNEWS__EN_7EB7C599F11A341092D3CE8122BF9F1), on November 06, 2026, and is solely responsible for the information contained therein.